The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
Open accessAbstract
Regulatory T (Treg) cells expressing the transcription factor Foxp3 have a critical role in the maintenance of immune homeostasis and prevention of autoimmunity. Recent advances in single cell analyses have revealed a range of Treg cell activation and differentiation states in different human pathologies. Here we review recent progress in the understanding of human Treg cell heterogeneity and function. We discuss these findings within the context of concepts in Treg cell development and function derived from preclinical models and insight from approaches targeting Treg cells in clinical settings. Distinguishing functional Treg cells from other T cells and understanding the context-dependent function(s) of different Treg subsets will be crucial to the development of strategies toward the selective therapeutic manipulation of Treg cells in autoimmunity and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These cells exert immunosuppressive effects through multiple mechanisms, including cytokine secretion, metabolic disruption of effector T cells, and modulation of antigen-presenting cells (APCs) (Bilate and Lafaille 2012; Josefowicz et al. 2012; Wing et al. 2019).”
From The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion (2026) · cites this paper as Wing et al. 2019
Citations
Cites
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Park, J., Adoro, S., Guinter, T. I., Erman, B., Alag, A., Catálfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationFreeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M., Ferguson, P., Whitesell, L., Kelly, T., Saulsbury, F., Chance, P., & Ochs, H. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,576
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 730
Han, Q., Wang, M., Dong, X., Wei, F., Luo, Y., & Sun, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.985815 · Cited by 31
Autoreactive T-Cells in Psoriasis: Are They Spoiled Tregs and Can Therapies Restore Their Functions?
Pietraforte, I., & Frasca, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054348 · Cited by 30
Xu, W., Zhang, W., Zhao, D., Wang, Q., Zhang, M., Li, Q., Zhu, W., & Xu, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1242909 · Cited by 31
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
Spasevska, I., Sharma, A., Steen, C. B., Josefsson, S. E., Blaker, Y. N., Kolstad, A., Rustad, E. H., Meyer, S., Isaksen, K. T., Chellappa, S., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010158 · Cited by 33
Xu, W., Zhou, B., Wang, P., Ma, Y., Yu, J., Mo, D., Wu, J., Ma, J., Wang, X., Miao, Y., et al. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101197 · Cited by 30
CCR8 + decidual regulatory T cells maintain maternal-fetal immune tolerance during early pregnancy
Li, Z., Si, P., Meng, T., Zhao, X., Zhu, C., Zhang, D., Meng, S., Li, N., Liu, R., Ni, T., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.ado2463 · Cited by 35
Lung Cancer Survival in Patients With Autoimmune Disease
Jacob, S. L., Rahbari, K. J., Tegtmeyer, K., Zhao, J. W., Tran, S., Helenowski, I., Zhang, H., Walunas, T. L., Varga, J., Dematte, J. E., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.29917 · Cited by 30
Degen, A., Krynytska, І., & Kamyshnyi, O. (2020) · Endocrine Regulations · doi:10.2478/enr-2020-0019 · Cited by 29
Wang, H., Fang, K., Yan, W., & Chang, X. (2021) · Journal of Innate Immunity · doi:10.1159/000516642 · Cited by 29
The tumor immune microenvironments of HPV + and HPV − head and neck cancers
Gameiro, S. F., Evans, A. M., & Mymryk, J. S. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1539 · Cited by 32
MiR-146a regulates regulatory T cells to suppress heart transplant rejection in mice
Lu, J., Wang, W., Li, P., Wang, X., Gao, C., Zhang, B., Du, X., Liu, Y., Yang, Y., & Qi, F. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00534-9 · Cited by 28
Fragile Treg cells: Traitors in immune homeostasis?
Song, X., Chen, R., Li, J., Zhu, Y., Jiao, J., Liu, H., Chen, Z., & Geng, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107297 · Cited by 29
Valta, M., Gazali, A. M., Viisanen, T., Ihantola, E., Ekman, I., Toppari, J., Knip, M., Veijola, R., Ilonen, J., Lempainen, J., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201948378 · Cited by 34
Bae, J. Y., Choi, K. U., Kim, A., Lee, S. J., Kim, K., Kim, J. Y., Lee, I. S., Chung, S. H., & Kim, J. I. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9225 · Cited by 28
Hui, Z., Zhang, J., Zheng, Y., Yang, L., Yu, W., An, Y., Wei, F., & Ren, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.619932 · Cited by 28
Antigen-Specific Treg Therapy in Type 1 Diabetes – Challenges and Opportunities
Serr, I., Drost, F., Schubert, B., & Daniel, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712870 · Cited by 31
Xia, Q., Sun, J., Xun, Y., Xiao, J., Liu, C., Xu, J., An, Y., Xu, M., Liu, Z., Wang, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864156 · Cited by 28
Liu, C., Zhu, J., Mi, Y., & Jin, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02663-z · Cited by 29
Chen, Y., Yin, J., Zhao, L., Zhou, G., Dong, S., Zhang, Y., Niu, P., Ren, H., Zheng, T., Yan, J., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03792-y · Cited by 29
Hoffmann, A. D., Weinberg, S. E., Swaminathan, S., Chaudhuri, S. M., Almubarak, H. F., Schipma, M. J., Mao, C., Wang, X., El-Shennawy, L., Dashzeveg, N. K., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2023.109634 · Cited by 30
ZFP91 is required for the maintenance of regulatory T cell homeostasis and function
Wang, A., Ding, L., Wu, Z., Ding, R., Teng, X.-L., Wang, F., Hu, Z., Chen, L., Yu, X., & Zou, Q. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201217 · Cited by 28
Zhou, J., Shao, Q., Lu, Y., Li, Y., Xu, Z., Zhou, B., Chen, Q., Li, X., Xu, X., Pan, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.960066 · Cited by 27
Chen, P., Wang, H., Tang, Z., Shi, J., Cheng, L., Zhao, C., Li, X., & Zhou, C. (2025) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2025.02.029 · Cited by 32
Cancer‐Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets
Li, Y., Liu, Q., Jing, X., Wang, Y., Jia, X., Yang, X., & Chen, K. (2025) · MedComm · doi:10.1002/mco2.70292 · Cited by 32
Yin, X., Wei, H., Wu, S., Wang, Z., Liu, B., Guo, L., Bi, H., & Guo, D. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106107 · Cited by 27
Chen, X., Wang, D., & Zhu, X. (2022) · Biomarker Research · doi:10.1186/s40364-022-00360-w · Cited by 27
He, J., Miao, R., Yao, C., Wang, H., & Liu, M. (2023) · Immunology · doi:10.1111/imm.13738 · Cited by 30
Zhang, Y., Huang, Y., Hong, Y., Lin, Z., Zha, J., Zhu, Y., Li, Z., Wang, C., Fang, Z., Zhou, Z., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111765 · Cited by 30
Niu, H.-Q., Zhao, X., Li, W., Xie, J.-F., Liu, X., Luo, J., Zhao, W., & Li, X. (2020) · BMC Immunology · doi:10.1186/s12865-020-00374-9 · Cited by 26
Cho, J. H., & Lim, Y. C. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2020.105084 · Cited by 27
Interpreting Immunoregulation in Lung Fibrosis: A New Branch of the Immune Model
Huaux, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690375 · Cited by 26
Zhan, Y., Zhang, Y., Mao, C., Li, J., Zhao, Y., Chen, Y., Liu, Z., & Lin, Y. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03943 · Cited by 26
Søndergaard, J. N., Tulyeu, J., Edahiro, R., Shirai, Y., Yamaguchi, Y., Murakami, T., Morita, T., Kato, Y., Hirata, H., Takeda, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217902120 · Cited by 24
Self-citationRole of heterogeneous regulatory T cells in the tumor microenvironment
Wei, T., Zhong, W., & Li, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104659 · Cited by 26
The role of the adaptive immune system in the initiation and persistence of multiple sclerosis
Afzali, A. M., & Korn, T. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101947 · Cited by 25
Immunomodulation of Myocardial Fibrosis
Sikking, M. A., Stroeks, S. L. V. M., Marelli‐Berg, F. M., Heymans, S. R. B., Ludewig, B., & Verdonschot, J. A. J. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.03.015 · Cited by 28
Qin, T., Jiang, T., Zhou, Z., Wu, M., Zhang, Y., Yang, Z., Zheng, Z., Jiang, Y., Wang, X., Luo, M., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.09.001 · Cited by 26
Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer
Andric, F., Al-Fairouzi, A., Wettergren, Y., Szeponik, L., Lindskog, E. B., Cusack, J. C., Tumusiime, G., Quiding‐Järbrink, M., & Ljungman, D. (2023) · Cancers · doi:10.3390/cancers15051457 · Cited by 25
Sheng, H., Marrero, I., Maricic, I., Fanchiang, S. S., Zhang, S., Sant’Angelo, D. B., & Kumar, V. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900832 · Cited by 26
Epstein–Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity
Nagata, K., & Hayashi, K. (2020) · Microorganisms · doi:10.3390/microorganisms8121875 · Cited by 25
Applications of pyroptosis activators in tumor immunotherapy
Bao, X., Sun, M., Meng, L., Zhang, H., Yi, X., & Zhang, P. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101191 · Cited by 24
Jamison, B. L., Lawrance, M. F., Wang, C. J., DeBerg, H. A., Ziegler, L., Sansom, D. M., Gavin, M. A., Walker, L. S. K., & Campbell, D. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114938 · Cited by 24
Current landscape of the immunoproteasome: implications for disease and therapy
Zou, Z., Hao, Y., Tao, Z., Ye, W., Luo, Z., Li, X., Li, R., Zheng, K., Xia, J., Guo, C., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02698-0 · Cited by 31
Feng, S., Mao, S., Dou, J., Li, W., Li, H., & Lin, J. (2019) · Chemical Science · doi:10.1039/c9sc02974e · Cited by 25
The functions of EZH2 in immune cells: Principles for novel immunotherapies
Shao, F.-F., Chen, B.-J., & Wu, G. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ru0520-311r · Cited by 23
Muhammad, F., Wang, D., McDonald, T., Walsh, M., Drenen, K., Montieth, A., Foster, C. S., & Lee, D. J. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102441 · Cited by 24
Ubiquitination in cancer: mechanisms and therapeutic opportunities
Zhu, S., Zhang, X., Liu, W., Zhou, Z. G., Xiong, S., Li, J., Chen, X., & Peng, C. (2025) · 癌症:英文版 · doi:10.1002/cac2.70044 · Cited by 25
Hira, S. K., Rej, A., Paladhi, A., Singh, R. K., Saha, J., Mondal, I., Bhattacharyya, S., & Manna, P. P. (2020) · iScience · doi:10.1016/j.isci.2020.101623 · Cited by 23
Liu, L., Hu, J., Wang, Y., Lei, H. C., & Xu, D. (2021) · Adipocyte · doi:10.1080/21623945.2021.1876375 · Cited by 26
Yang, J., Zhong, M., Hong, K., Yang, Q., Zhang, E., Zhou, D., Xia, J., Chen, Y., Sun, M., Zhao, B., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1259 · Cited by 24
Tissue Nutrient Environments and Their Effect on Regulatory T Cell Biology
Blagih, J., Hennequart, M., & Zani, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637960 · Cited by 25
An, Y., Sun, J., Xu, M., Xu, J., Ma, S.-Y., Liu, C., Liu, Z., Wang, S., & Xia, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049884 · Cited by 24
Cell and biomaterial delivery strategies to induce immune tolerance
Scotland, B. L., Shaw, J. R., Dharmaraj, S., Caprio, N., Cottingham, A. L., Lasola, J. J., Sung, J. J., & Pearson, R. M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115141 · Cited by 26
Short-term cold exposure supports human Treg induction in vivo
Becker, M., Serr, I., Salb, V. K., Ott, V. B., Mengel, L. A., Blüher, M., Weigmann, B., Hauner, H., Tschöp, M. H., & Daniel, C. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.002 · Cited by 24
An, Q., Duan, L., Wang, Y., Wang, F., Liu, X., Liu, C., & Hu, Q. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06167-1 · Cited by 28
Lee, C., Park, Y. W., Park, M. H., Lee, Y. J., & Rhee, I. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117087 · Cited by 22
Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis
Huang, C., Shen, Y., Shen, M., Fan, X., Men, R., Ye, T., & Yang, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.726128 · Cited by 22
Louis, K., Fadakar, P. K., Macedo, C., Yamada, M., Lucas, M., Gu, X., Zeevi, A., Randhawa, P. S., Lefaucheur, C., & Metes, D. (2022) · Kidney International · doi:10.1016/j.kint.2021.12.027 · Cited by 22
Cole, C. B., Morelli, M. P., Fantini, M. C., Miettinen, M., Fetsch, P. A., Peer, C. J., Figg, W. D., Yin, T., Houston, N. D., McCoy, A., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02649-6 · Cited by 22
Hu, C., Sameshima, J., Yokomizo, S., Sueyoshi, T., Nagano, H., Miyahara, Y., Sakamoto, T., Fujii, S., Kiyoshima, T., Guy, T. V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305783 · Cited by 23
TNFR2-expressing CD4+Foxp3+ regulatory T cells in cancer immunology and immunotherapy
He, J., Li, R., Chen, Y., Yuanjia, H., & Chen, X. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.03.010 · Cited by 22
Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies
Golay, J., & Andrea, A. E. (2020) · Antibodies · doi:10.3390/antib9020017 · Cited by 24
Autoimmune Responses in Oncology: Causes and Significance
Bareke, H., Juanes‐Velasco, P., Landeira‐Viñuela, A., Hernández, Á., Cruz, J. J., Bellido, L., Fonseca, E., Cárdenas, A. N., Montalvillo, E., Góngora, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158030 · Cited by 24
Jin, Y., Jiang, J. F., Mao, W. B., Bai, M., Chen, Q., & Zhu, J. Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216858 · Cited by 24
Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy
Ryba-Stanisławowska, M. E. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00992-0 · Cited by 23
Bakker, N. A. M., Garner, H., van Dyk, E., Champanhet, E., Klaver, C., Duijst, M., Voorwerk, L., Nederlof, I., Voorthuis, R. A. B., Liefaard, M. C., et al. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00721-2 · Cited by 27
An, J., Ding, Y., Yu, C., Li, J., You, S., Liu, Z., Song, P., & Zou, M. (2021) · iScience · doi:10.1016/j.isci.2021.103570 · Cited by 21
Hynne, H., Aqrawi, L. A., Jensen, J. L., Thiede, B., Palm, Ø., Amdal, C. D., Westgaard, K. L., Herlofson, B. B., Utheim, T. P., & Galtung, H. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073714 · Cited by 22
CD4+CD25+ T regulatory cells in renal transplantation
Cheung, J., Zahorowska, B., SURANYI, M. G., Wong, J. K. W., Diep, J., Spicer, S. T., Verma, N. D., Hodgkinson, S. J., & Hall, B. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1017683 · Cited by 21
Sun, Y., Wang, Y., Lu, F. Y., Zhao, X., Nie, Z., & He, B. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03080-1 · Cited by 21
Biomaterial-enabled therapeutic modulation of cGAS-STING signaling for enhancing antitumor immunity
Liu, Y., Yang, F., Wang, X., Yang, B., Li, M., & Luo, Z. Y. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.03.026 · Cited by 24
Mendu, S. K., Stremska, M. E., Schappe, M. S., Moser, E. K., Krupa, J. K., Rogers, J. S., Stipes, E. J., Parker, C. A., Braciale, T. J., Perry, J. S. A., et al. (2020) · Science Signaling · doi:10.1126/scisignal.abb0619 · Cited by 22
Martín‐Cruz, L., Benito‐Villalvilla, C., Sirvent, S., Angelina, A., & Palomares, Ó. (2024) · International Archives of Allergy and Immunology · doi:10.1159/000536335 · Cited by 21
Wang, C., Yang, M., Zhong, Y., Cao, K., Wang, X., Zhang, C., Wang, Y., He, M., Lu, J., Zhang, G., et al. (2025) · 癌症:英文版 · doi:10.1002/cac2.70021 · Cited by 21
Urakawa, S., Yamasaki, M., Makino, T., Kurokawa, Y., Yamamoto, K., Goto, K., Haruna, M., Hirata, M., Morimoto-Okazawa, A., Kawashima, A., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02696-4 · Cited by 20
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer
Shin, D. S., Park, K., Garon, E. B., & Dubinett, S. M. (2022) · Seminars in Oncology · doi:10.1053/j.seminoncol.2022.06.005 · Cited by 20
Chang, M., He, Y., Liu, C., Lin, R., Huang, X., Liang, D., Zhang, J., & Lü, Y. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.76573 · Cited by 20
Elsaghir, A., El-Sabaa, E. M. W., Zahran, A. M., Mandour, S. A., Salama, E. H. A., Aboulfotuh, S., El-morshedy, R. M., Tocci, S., Mandour, A., Ali, W. E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417614 · Cited by 20
Non-canonical PD-1 signaling in cancer and its potential implications in clinic
Zha, H., Jiang, Y., Wang, X., Shang, J., Wang, N., Yu, L., Zhao, W., Li, Z., Zhang, X., Zhang, X., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001230 · Cited by 24
Huang, H., Yang, C., Li, S., Huang, Z., Tan, J., Chen, C., Li, J., Wang, M., & Li, H. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119958 · Cited by 19
Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target
Liu, M., Yang, M., Qi, Y., Ma, Y., Guo, Q., Guo, L., Liu, C., Liu, W., Xiao, L., & Yang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1627161 · Cited by 22
Liu, Q.-X., Zhu, Y., Yi, H., Shen, Y., Wang, L., Cheng, S., Xu, P., Xu, H., Zhou, L., Huang, Y., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.93349 · Cited by 19
Wang, Y., Yang, J., Zhang, Q., Xia, J., & Wang, Z. (2019) · Translational Andrology and Urology · doi:10.21037/tau.2019.10.19 · Cited by 19
Yasunaga, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00979 · Cited by 19
Peng, Y., Yang, J., Guo, D., Zheng, C., Sun, H., Zhang, Q., Zou, S., Zhang, Y., Luo, K., & Candiotti, K. A. (2020) · BMC Anesthesiology · doi:10.1186/s12871-020-01129-0 · Cited by 19
Bone Morphogenic Proteins Are Immunoregulatory Cytokines Controlling FOXP3+ Treg Cells
Browning, L. M., Miller, C., Kuczma, M., Pietrzak, M., Jing, Y., Rempała, G. A., Muranski, P. J., Ignatowicz, L., & Kraj, P. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108219 · Cited by 20
Norton, D. L., Ceppe, A., Tune, M. K., McCravy, M. S., Devlin, T., Drummond, M., Carson, S. S., Vincent, B. G., Hagan, R. S., Dang, H., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02595-3 · Cited by 20
Go, E., Yoo, S., Choi, S., Sun, P., Jung, M. K., Kwon, S., Heo, B. Y., Kim, Y., Kang, J., Kim, J., et al. (2021) · Cells · doi:10.3390/cells10040801 · Cited by 19
Regulatory CD8 + T cells suppress disease
Levescot, A., & Cerf–Bensussan, N. (2022) · Science · doi:10.1126/science.abp8243 · Cited by 19
Mechanisms of autoimmune hepatitis
Cardon, A., Conchon, S., & Renand, A. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000704 · Cited by 18
Beyond the blood–brain barrier: unraveling T cell subsets in CNS immunity and disease
Shokr, M. M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01955-z · Cited by 21
Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer
Qian, Y., Wei, J., Lu, W., Sun, F., Hwang, M., Jiang, K., Fu, D., Zhou, X., Kong, X., Zhu, Y., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.619611 · Cited by 18
The Natural History of T Cell Metabolism
Braun, M. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136779 · Cited by 18
Wei, X., Zhang, X., Wang, S., Wang, Y., Ji, C., Yao, L., & Song, N. (2022) · PubMed Central · Cited by 18
long, Y. N., Zhao, X. T., Xia, C.-S., Li, X., Fan, C., Liu, C., & Wang, C. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12842 · Cited by 18
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation
Mancusi, A., Piccinelli, S., Velardi, A., & Pierini, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02901 · Cited by 18
Sakai, R., Ito, M., Yoshimoto, K., Chikuma, S., Kurasawa, T., Kondo, T., Suzuki, K., Takeuchi, T., Amano, K., & Yoshimura, A. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1203 · Cited by 18
Guan, X., Li, J., Cai, J., Huang, S., Liu, H., Wang, S., Zhang, X., Sun, Y., Liu, H., Xie, G., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.130579 · Cited by 19
Chi, F., Chen, L., Jin, X., He, G., Liu, Z., & Han, S. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113035 · Cited by 19
Single cell suppression profiling of human regulatory T cells
Søndergaard, J. N., Tulyeu, J., Priest, D., Sakaguchi, S., & Wing, J. B. (2025) · Nature Communications · doi:10.1038/s41467-024-55746-1 · Cited by 17
Self-citation
Metadata
- Authors
- Wing, J. B., Tanaka, A., & Sakaguchi, S.
- Affiliations
- Immunology Frontier Research Center, The University of Osaka (JP)
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 50
- Issue
- 2
- Pages
- 302-316
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2917646500
- Cited by
- 726
- References
- 180
- Citations by year
- 2026: 55 · 2025: 95 · 2024: 117 · 2023: 120 · 2022: 114 · 2021: 105 · 2020: 87 · 2019: 33
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (16H06295, 18K07175)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- regulatory T cells, Foxp3, Treg differentiation, autoimmunity, tumor immunology, immune homeostasis, Treg therapy, single-cell analysis
- MeSH terms
- Animals, Cell Differentiation, Gene Expression Regulation, Humans, Neoplasms, Autoimmunity, T-Lymphocyte Subsets, Genetic Heterogeneity, T-Lymphocytes, Regulatory, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review